GO:0002283 neutrophil activation involved in immune response: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002283 (neutrophil activation involved in immune response) describes the morphological and behavioral changes of neutrophils after exposure to cytokines, chemokines, cellular ligands, or soluble factors, leading to initiation or perpetuation of an immune response.
• Neutrophil activation is a central node in innate and adaptive immunity, bridging acute inflammation, immune complex clearance, and chronic inflammatory disease [2,3].
• Key activating inputs include immune complexes, crystals (e.g., monosodium urate), microbial metabolites, and cytokines such as CXCL2 [6,7,8,1].
• Activated neutrophils release neutrophil extracellular traps (NETs), which further amplify proinflammatory functions in an autocrine/paracrine manner.
• Dysregulated neutrophil activation contributes to inflammatory bowel disease, polymyalgia rheumatica, gout, hepatocellular carcinoma progression, and recurrent pregnancy loss [1,6,7,8,5].
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling neutrophil activation [2,3].
Description
GO:0002283, neutrophil activation involved in immune response, is a biological process term that captures the coordinated change in morphology and behavior of neutrophils following exposure to cytokines, chemokines, cellular ligands, or soluble factors, ultimately initiating or perpetuating an immune response. Neutrophils are the most abundant circulating leukocytes and act as first responders that integrate signals from the tissue microenvironment to execute antimicrobial, inflammatory, and immunoregulatory programs [2,3]. Because activation is not a single event but a continuum spanning priming, adhesion, degranulation, respiratory burst, and extracellular trap formation, the term encompasses a broad set of cellular transitions that are experimentally tractable and clinically relevant [2,4]. Research into GO:0002283 matters because neutrophil activation sits at the intersection of host defense and tissue injury. Activated neutrophils can clear pathogens and immune complexes, but when dysregulated they drive chronic inflammation, autoimmunity, and tumor progression [3,6,7]. For example, immune complex-mediated neutrophil activation is observed in polymyalgia rheumatica, and crystal-induced activation underlies gouty inflammation [7,8]. In inflammatory bowel disease, the microbial metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation, illustrating that activation is tunable by environmental cues. Mechanistically, neutrophil activation is initiated by receptor engagement (e.g., Fc receptors, chemokine receptors, integrins) and propagated by intracellular signaling, cytoskeletal rearrangement, and granule mobilization [2,8]. NETs released by activated neutrophils can themselves activate proinflammatory functions in human neutrophils, creating a feed-forward loop. This complexity makes GO:0002283 a rich area for CRISPR-based functional genomics, where candidate genes can be tested for causal roles in activation phenotypes [2,3].
neutrophil activation involved in immune response At A Glance
| GO ID | GO:0002283 |
|---|---|
| GO term | neutrophil activation involved in immune response |
| Ontology | biological_process |
| Synonym | neutrophil activation during immune response |
| Definition | The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| Major function | Initiation and perpetuation of immune responses through neutrophil effector programs such as degranulation, respiratory burst, and NET formation [2,4]. |
| Key activating stimuli | Immune complexes, crystals, chemokines (e.g., CXCL2), microbial metabolites, and cytokines [1,6,7,8]. |
| Associated diseases | Inflammatory bowel disease, polymyalgia rheumatica, gout, hepatocellular carcinoma, recurrent pregnancy loss [1,5,6,7,8]. |
| Research methods | CRISPR knockout/knock-in, NET assays, chemotaxis assays, cytokine profiling, and transcriptomics [2,3,4]. |
What Is GO:0002283?
In our own words, GO:0002283 describes the process by which a neutrophil changes its shape and behavior after encountering a cytokine, chemokine, cellular ligand, or soluble factor, and as a result contributes to starting or sustaining an immune response. It is a biological process term that covers the transition from a resting or primed neutrophil to an activated state with enhanced effector functions, including adhesion, migration, degranulation, phagocytosis, respiratory burst, and NET formation [2,4].
Why Is neutrophil activation involved in immune response Important in Cell Biology?
GO:0002283 is important because neutrophil activation is a decisive checkpoint in innate and adaptive immunity, and its dysregulation is a common denominator in acute and chronic inflammatory diseases [2,3]. Understanding the molecular triggers and feedback loops of activation can reveal therapeutic targets and biomarkers, while also explaining how neutrophils shape tumor immunity and pregnancy outcomes [5,6].
• Neutrophils are first responders that link innate sensing to adaptive immune activation.
• Activation states determine whether neutrophils are protective or tissue-damaging in inflammation.
• Immune complex-mediated activation is directly implicated in polymyalgia rheumatica.
• Crystal-induced activation drives gouty inflammation and joint damage.
• Microbial metabolites such as butyrate can constrain neutrophil functions and reduce mucosal inflammation in IBD.
• NETs amplify proinflammatory neutrophil functions, creating a self-reinforcing activation loop.
• CXCL2-neutrophil axis promotes immunosuppression and HCC progression.
• Aberrant neutrophil activation has been linked to recurrent pregnancy loss through Th cell imbalance.
• CRISPR screens can identify causal genes controlling activation phenotypes [2,3].
• Targeting activation pathways may yield new anti-inflammatory therapeutics.
What Happens During neutrophil activation involved in immune response?
Priming and receptor engagement
In simple terms: The neutrophil gets ready and receives the first signal.
Activation begins when neutrophils encounter cytokines, chemokines, cellular ligands, or soluble factors that engage surface receptors, leading to priming and a lowered threshold for subsequent stimulation. Immune complexes and crystals can serve as activating ligands in disease settings [7,8]. This step is characterized by early signaling events that prepare the cell for a full response.
Adhesion, migration, and cytoskeletal rearrangement
In simple terms: The neutrophil changes shape and moves toward the signal.
Following receptor engagement, neutrophils undergo morphological changes and cytoskeletal reorganization that support adhesion to endothelium and migration to inflammatory sites. These behavioral changes are part of the definition of GO:0002283 and are required for neutrophils to reach and act within tissues [2,3].
Degranulation and respiratory burst
In simple terms: The neutrophil releases stored weapons and produces reactive molecules.
Activated neutrophils mobilize granules and produce reactive oxygen species as part of their effector program. Crystal-induced activation specifically triggers these responses in gout-associated inflammation. These events contribute to pathogen killing but can also damage host tissue when unchecked.
NET formation and feed-forward activation
In simple terms: The neutrophil casts nets that further activate other neutrophils.
Neutrophil extracellular traps (NETs) released by activated neutrophils can activate proinflammatory functions of human neutrophils, establishing a positive feedback loop. This amplifies the activation state and perpetuates the immune response, consistent with the GO definition's emphasis on initiation or perpetuation [2,4].
Resolution or chronicity
In simple terms: The response either shuts down or becomes long-lasting.
Activation is normally resolved, but persistent stimuli such as immune complexes, crystals, or tumor-derived chemokines can drive chronic inflammation [3,6,7,8]. Butyrate and other microbial metabolites can constrain neutrophil functions and promote resolution in mucosal inflammation. The balance between resolution and chronicity determines disease outcomes.
Key Genes Involved in GO:0002283 neutrophil activation involved in immune response
The following genes and proteins are experimentally implicated in neutrophil activation involved in immune response, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL2 | Chemokine that recruits and activates neutrophils | Promotes HCC progression through neutrophil-induced immunosuppression |
| FCGR | Fc gamma receptors bind immune complexes | Mediates immune complex-mediated neutrophil activation in polymyalgia rheumatica |
| ITGB2 | Integrin beta-2 involved in adhesion | Supports neutrophil adhesion and migration during activation |
| SELPLG | Selectin ligand for rolling adhesion | Facilitates neutrophil-endothelial interactions |
| MPO | Myeloperoxidase in azurophilic granules | Marker of degranulation and oxidative burst |
| ELANE | Neutrophil elastase | Granule protease released during activation |
| MMP9 | Matrix metalloproteinase-9 | Granule enzyme involved in tissue remodeling |
| CYBB | NADPH oxidase subunit | Required for respiratory burst |
| PADI4 | Peptidylarginine deiminase 4 | Citrullination involved in NET formation |
| TLR4 | Toll-like receptor 4 | Senses ligands that prime neutrophils |
| NLRP3 | Inflammasome sensor | Crystal-induced activation pathways |
| IL1B | Proinflammatory cytokine | Amplifies neutrophil activation |
| TNF | Proinflammatory cytokine | Priming and activation of neutrophils |
| CXCR2 | Chemokine receptor | Mediates neutrophil recruitment |
| S100A8/A9 | Calcium-binding proteins | Released during activation and inflammation |
| ARG1 | Arginase 1 | Immunosuppressive function in activated neutrophils |
| CD177 | Neutrophil surface glycoprotein | Associated with activation states |
How Is neutrophil activation involved in immune response Regulated?
Neutrophil activation is regulated by a balance of activating and inhibitory signals. Cytokines and chemokines such as TNF and CXCL2 promote activation, while microbial metabolites like butyrate can constrain neutrophil functions and ameliorate mucosal inflammation [1,6]. Immune complexes and crystals provide persistent activating stimuli that can override resolution mechanisms [7,8]. NETs further amplify activation through feed-forward loops. The interplay between these regulators determines whether activation is transient and protective or chronic and pathogenic.
neutrophil activation involved in immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL2 | HCC progression via neutrophil immunosuppression | Knockout in hepatoma models |
| FCGR | Polymyalgia rheumatica | Point mutation to alter immune complex binding |
| PADI4 | NET formation and autoimmunity | Knockout in neutrophil-like cells |
| NLRP3 | Gouty inflammation | Knock-in of gain-of-function variants |
| ARG1 | Tumor immunosuppression | Overexpression in myeloid cells |
Inflammatory bowel disease
In IBD, neutrophil activation contributes to mucosal inflammation, and the microbial metabolite butyrate constrains neutrophil functions and ameliorates inflammation. This highlights activation as a tunable process influenced by the microbiome.
Polymyalgia rheumatica and gout
Immune complex-mediated neutrophil activation occurs in polymyalgia rheumatica, and crystal-induced activation drives gouty inflammation [7,8]. These diseases exemplify how specific ligands trigger GO:0002283 in sterile inflammation [7,8].
Hepatocellular carcinoma
Group-2 innate lymphoid cells promote HCC progression through a CXCL2-neutrophil-induced immunosuppression axis, linking neutrophil activation to tumor progression.
Recurrent pregnancy loss
Th cell profiles, including Th17 responses, have been associated with recurrent pregnancy loss, and neutrophil activation may contribute to the inflammatory milieu.
From neutrophil activation involved in immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive neutrophil activation? | CRISPR knockout in primary neutrophils or HL-60 cells |
| Does a point mutation alter activation? | Point-mutation knock-in |
| Does a disease variant affect activation? | Knock-in of patient variants |
| Can a tagged protein track activation? | Tagged knock-in |
| Does overexpression enhance activation? | Overexpression in neutrophil-like cell lines |
| Which genes are essential for activation? | CRISPR library screening [2,3] |
How to Study the neutrophil activation involved in immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Chemotaxis assay | Directed migration | Assess activation-induced motility |
| Degranulation assay | Release of granule proteins | Quantify MPO/ELANE release |
| Respiratory burst assay | ROS production | Measure oxidative burst |
| NET formation assay | Extracellular trap release | Study feed-forward activation |
| RNA-seq | Transcriptional changes | Identify activation signatures |
| Proteomics | Protein abundance and modifications | Discover activation markers |
| Flow cytometry | Surface marker expression | Classify activation states |
| CRISPR screen | Gene essentiality for activation | Identify causal regulators [2,3] |
Functional activation assays
Neutrophil activation can be measured by chemotaxis, degranulation markers (e.g., MPO, ELANE), respiratory burst, and NET formation assays [2,4]. These readouts directly map to GO:0002283.
Transcriptomics and proteomics
RNA-seq and proteomics can identify gene expression changes during activation, revealing pathways and candidate regulators [3,6]. Such datasets help prioritize genes for CRISPR validation.
Imaging and flow cytometry
Imaging and flow cytometry assess morphological changes, surface marker expression, and NET release, providing single-cell resolution of activation states [2,4].
CRISPR screening
Pooled CRISPR screens can systematically identify genes required for or modulating neutrophil activation phenotypes [2,3]. Hits can be validated in secondary assays.
How CRISPR Can Be Used to Study GO:0002283 neutrophil activation involved in immune response
Knockout
CRISPR knockout of candidate genes in neutrophil-like cell lines or primary cells can test whether a gene is required for activation phenotypes such as degranulation or NET formation [2,4]. This provides causal evidence for gene function in GO:0002283.
Point Mutation
Point-mutation knock-in can model disease-associated variants that alter activation, such as Fc receptor variants in immune complex-mediated activation. This approach dissects specific residues controlling ligand binding or signaling.
Knock-in
Knock-in of tagged proteins or disease variants enables tracking of activation dynamics and modeling of crystal-induced pathways [4,8]. Tagged knock-in allows visualization of protein localization during activation.
Overexpression
Overexpression of genes such as ARG1 or CXCL2 can enhance activation or immunosuppressive functions, modeling tumor-associated neutrophil states. This helps establish sufficiency in activation pathways.
How EDITGENE Supports neutrophil activation involved in immune response Research
Researchers studying neutrophil activation involved in immune response-related genes often need to determine whether a candidate gene is causally involved in activation phenotypes or merely correlated with them. EDITGENE provides the CRISPR tools and services to move from correlation to causation in neutrophil biology.
Contact EDITGENE today to design your custom CRISPR model for neutrophil activation involved in immune response research.
Frequently Asked Questions About neutrophil activation involved in immune response
What is GO:0002283?
GO:0002283 is the biological process term for neutrophil activation involved in immune response, defined as the change in morphology and behavior of a neutrophil after exposure to cytokines, chemokines, cellular ligands, or soluble factors, leading to initiation or perpetuation of an immune response.
What genes are involved in neutrophil activation involved in immune response?
Genes such as CXCL2, FCGR, ITGB2, MPO, ELANE, CYBB, PADI4, and ARG1 have been implicated in neutrophil activation and its downstream effects [2,4,6,7].
How is neutrophil activation triggered?
It is triggered by receptor engagement with cytokines, chemokines, immune complexes, crystals, or microbial metabolites, which prime and activate neutrophils [1,2,7,8].
What are NETs and how do they relate to neutrophil activation?
NETs are neutrophil extracellular traps that can further activate proinflammatory functions of human neutrophils, creating a feed-forward loop.
Which diseases involve dysregulated neutrophil activation?
Inflammatory bowel disease, polymyalgia rheumatica, gout, hepatocellular carcinoma, and recurrent pregnancy loss have been linked to neutrophil activation [1,5,6,7,8].
How can CRISPR be used to study neutrophil activation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in activation phenotypes [2,3,7].
What methods measure neutrophil activation?
Chemotaxis, degranulation, respiratory burst, NET formation, RNA-seq, proteomics, flow cytometry, and CRISPR screens are commonly used [2,3,4,6].
Can butyrate affect neutrophil activation?
Yes, the microbial metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in IBD.
What is the role of CXCL2 in neutrophil activation?
CXCL2 recruits and activates neutrophils and has been linked to immunosuppression in HCC progression.
How does crystal-induced neutrophil activation occur?
Crystals such as monosodium urate trigger activation pathways that contribute to gouty inflammation.
Conclusion
GO:0002283, neutrophil activation involved in immune response, is a central biological process that governs how neutrophils respond to diverse stimuli and shape immune outcomes. Its dysregulation contributes to a wide range of inflammatory and malignant diseases, making it a high-value target for mechanistic and therapeutic research [3,6,7,8]. CRISPR-based models and functional genomics provide powerful tools to dissect the causal genes and pathways controlling neutrophil activation [2,4].
References
- 1. Li G et al.. 2021. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.. Gut Microbes 13(1):1968257 PMID: 34494943
- 2. Mantovani A et al.. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity.. Nat Rev Immunol 11(8):519-31 PMID: 21785456
- 3. Torfs K et al.. 2026. Neutrophils as critical orchestrators of chronic inflammation.. Cell Mol Immunol 23(2):123-149 PMID: 41530536
- 4. Dömer D et al.. 2021. Neutrophil Extracellular Traps Activate Proinflammatory Functions of Human Neutrophils.. Front Immunol 12:636954 PMID: 34168641
- 5. Wang W et al.. 2020. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells.. Front Immunol 11:2025 PMID: 32973809
- 6. Xu X et al.. 2021. Group-2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2-Neutrophil-Induced Immunosuppression.. Hepatology 74(5):2526-2543 PMID: 33829508
- 7. Michailidou D et al.. 2023. Immune complex-mediated neutrophil activation in patients with polymyalgia rheumatica.. Rheumatology (Oxford) 62(8):2880-2886 PMID: 36562570
- 8. Popa-Nita O et al.. 2010. Crystal-induced neutrophil activation.. Immunol Cell Biol 88(1):32-40 PMID: 19949421
